Announces that it is extending the expiry date and amending the exercise price of the common share purchase warrants of the Company issued on August 13, 2019, June 30, 2020 and February 24, 2021. The amendments will take effect on December 29, 2023. Antibe Therapeutics Inc. shares T.ATE are trading unchanged at $0.70.
Stocks in play: Antibe Therapeutics Inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)